West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics

West Pharmaceutical Services, Inc. (WST)

Today's Latest Price: $266.38 USD

7.17 (-2.62%)

Updated Aug 10 7:00pm

Add WST to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

WST Stock Summary

  • WST has a higher market value than 90.65% of US stocks; more precisely, its current market capitalization is $20,199,119,655.
  • WST's went public 32.61 years ago, making it older than 89.34% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for WST is currently 48.13, higher than 92.4% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to West Pharmaceutical Services Inc are SLP, AMRN, CARG, ALGN, and INSP.
  • Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.
WST Daily Price Range
WST 52-Week Price Range

WST Stock Price Chart Technical Analysis Charts

WST Price/Volume Stats

Current price $266.38 52-week high $279.54
Prev. close $273.55 52-week low $124.53
Day low $265.64 Volume 617,851
Day high $273.41 Avg. volume 660,112
50-day MA $235.13 Dividend yield 0.23%
200-day MA $179.65 Market Cap 19.67B

West Pharmaceutical Services, Inc. (WST) Company Bio

West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.

WST Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$266.38$90.91 -67%

We started the process of determining a valid price forecast for West Pharmaceutical Services Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that West Pharmaceutical Services Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of West Pharmaceutical Services Inc, consider:

  • The company's debt burden, as measured by earnings divided by interest payments, is 42.96; that's higher than 90.53% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than just 7.53% of the free cash flow producing stocks we're observing.
  • WST's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 51.57% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of West Pharmaceutical Services Inc? See MTD, OFIX, ABT, SRDX, and BAX.

WST Latest News Stream

Event/Time News Detail
Loading, please wait...

WST Latest Social Stream

Loading social stream, please wait...

View Full WST Social Stream

Latest WST News From Around the Web

Below are the latest news stories about West Pharmaceutical Services Inc that investors may wish to consider to help them evaluate WST as an investment opportunity.

Top Health Care Stocks for August 2020

Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 17.0% compared to the S&P 500's total return of 9.0% over the past 12 months. Several of these companies have received U.S. Emergency Use Authorization to develop either tests or treatments for COVID-19, sharply boosting their share price.

Yahoo | July 28, 2020

West Pharmaceutical Services (WST) Q2 2020 Earnings Call Transcript

WST earnings call for the period ending June 30, 2020.

Yahoo | July 24, 2020

West Pharmaceutical EPS beats by $0.34, beats on revenue

West Pharmaceutical (WST): Q2 Non-GAAP EPS of $1.25 beats by $0.34; GAAP EPS of $1.21 beats by $0.31.Revenue of $527.2M (+12.2% Y/Y) beats by $31.11M.Press Release...

Seeking Alpha | July 23, 2020

West Pharmaceutical Services, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by West Pharmaceutical Services, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | July 23, 2020

The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) BioLife Solutions Inc (NASDAQ: BLFS ) CALLIDITAS THER/S ADR (NASDAQ: CALT ) Catalent Inc (NYSE: CTLT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Hologic, Inc. (NASDAQ: HOLX ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunic Inc (NASDAQ: IMUX ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) ( reported forecast-beating second-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Novo Nordisk A/S (NYSE: NVO ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Otonomy Inc (NASDAQ: OTIC ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) TFF Phar...

Benzinga | July 23, 2020

Read More 'WST' Stories Here

WST Price Returns

1-mo 14.77%
3-mo 29.60%
6-mo 64.48%
1-year 85.77%
3-year 218.33%
5-year 362.03%
YTD 77.65%
2019 54.13%
2018 -0.08%
2017 17.02%
2016 41.87%
2015 14.03%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.12 seconds.